Orrick Advises Aledade on $123 Million Series E


Orrick congratulates healthcare technology client Aledade on its $123 million Series E financing round. Returning investor OMERS Growth Equity led the round, which also included Fidelity Management & Research Company and other current investors.

Founded in 2014, Aledade partners with independent practices, health centers, and clinics to build and lead Accountable Care Organizations anchored in primary care. Aledade plans to use the new capital to support investments in value-based care for more seniors covered by Medicare Advantage and innovation that improves patient care and increases medical cost savings, including expanded offerings through its new health services subsidiary, Aledade Care Solutions.

The Orrick team advising Aledade was led by Stephen Thau and included Andy Bloom and Michael LaBlanc.